Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liliana Rodrigues Loureiro

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Small Science|May 21, 2025
Toward Personalized Immunotherapeutic Drug Monitoring with Multiplexed Extended-Gate Field-Effect-Transistor BiosensorsTrang-Anh Nguyen-Le, Christin Neuber, Isli Cela, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 20, 2024
<sup>64</sup>Cu tumor labeling with hexadentate picolinic acid-based bispidine immunoconjugatesManja Kubeil, Christin Neuber, Miriam Starke, et al.
International Journal of Molecular Sciences|July 27, 2022
Combining Radiation- with Immunotherapy in Prostate Cancer: Influence of Radiation on T CellsDiana Lindner, Claudia Arndt, Liliana Rodrigues Loureiro, et al.
Oncotargets and Therapy|July 2, 2020
Highly Efficient Targeting of EGFR-Expressing Tumor Cells with UniCAR T Cells via Target Modules Based on Cetuximab<sup>®</sup>Justyna Jureczek, Anja Feldmann, Ralf Bergmann, et al.
Oncoimmunology|September 14, 2020
Versatile chimeric antigen receptor platform for controllable and combinatorial T cell therapyAnja Feldmann, Anja Hoffmann, Ralf Bergmann, et al.
Cancers|October 13, 2021
Targeting Acute Myeloid Leukemia Using the RevCAR Platform: A Programmable, Switchable and Combinatorial StrategyEnrico Kittel-Boselli, Karla Elizabeth González Soto, Liliana Rodrigues Loureiro, et al.
Journal for Immunotherapy of Cancer|February 28, 2024
CAR-mediated targeting of NK cells overcomes tumor immune escape caused by ICAM-1 downregulationJiri Eitler, Wiebke Rackwitz, Natalie Wotschel, et al.
Frontiers in Immunology|June 29, 2023
A novel ACE2 decoy for both neutralization of SARS-CoV-2 variants and killing of infected cellsAlexandra Kegler, Laura Drewitz, Claudia Arndt, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Small Science|May 21, 2025
Toward Personalized Immunotherapeutic Drug Monitoring with Multiplexed Extended-Gate Field-Effect-Transistor BiosensorsTrang-Anh Nguyen-Le, Christin Neuber, Isli Cela, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 20, 2024
<sup>64</sup>Cu tumor labeling with hexadentate picolinic acid-based bispidine immunoconjugatesManja Kubeil, Christin Neuber, Miriam Starke, et al.
International Journal of Molecular Sciences|July 27, 2022
Combining Radiation- with Immunotherapy in Prostate Cancer: Influence of Radiation on T CellsDiana Lindner, Claudia Arndt, Liliana Rodrigues Loureiro, et al.
Oncotargets and Therapy|July 2, 2020
Highly Efficient Targeting of EGFR-Expressing Tumor Cells with UniCAR T Cells via Target Modules Based on Cetuximab<sup>®</sup>Justyna Jureczek, Anja Feldmann, Ralf Bergmann, et al.
Oncoimmunology|September 14, 2020
Versatile chimeric antigen receptor platform for controllable and combinatorial T cell therapyAnja Feldmann, Anja Hoffmann, Ralf Bergmann, et al.
Cancers|October 13, 2021
Targeting Acute Myeloid Leukemia Using the RevCAR Platform: A Programmable, Switchable and Combinatorial StrategyEnrico Kittel-Boselli, Karla Elizabeth González Soto, Liliana Rodrigues Loureiro, et al.
Journal for Immunotherapy of Cancer|February 28, 2024
CAR-mediated targeting of NK cells overcomes tumor immune escape caused by ICAM-1 downregulationJiri Eitler, Wiebke Rackwitz, Natalie Wotschel, et al.
Frontiers in Immunology|June 29, 2023
A novel ACE2 decoy for both neutralization of SARS-CoV-2 variants and killing of infected cellsAlexandra Kegler, Laura Drewitz, Claudia Arndt, et al.
Pageof 1